What Does Nemifitide diTFA Mean?
MI-CP151 was a stage 1b randomised, double-blind, placebo controlled, dose-escalation, multicentre examine To guage multiple intravenous doses of sifalimumab, in adult clients with dermatomyositis or polymyositis (NCT00533091). Most important trial targets were to evaluate the safety and tolerability of sifalimumab in dermatomyositis or polymyositi